Advertisement

Topics

Ronald E. Blaylock Elected to Pfizer’s Board of Directors

16:15 EST 23 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Pfizer Inc. today announced the election of Ronald E. Blaylock to its Board of Directors, effective immediately. Mr. Blaylock was also appointed to the Corporate Governance and Science and Technology Committees of Pfizer’s Boa...

Other Sources for this Article

Pfizer Inc.
Media:
Joan Campion, (212) 733-2798
joan.campion@pfizer.com
or
Investor:
Bryan Dunn, (212) 733-8917
bryan.dunn@pfizer.com

NEXT ARTICLE

More From BioPortfolio on "Ronald E. Blaylock Elected to Pfizer’s Board of Directors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...